Skip to main content

Advertisement

SpringerLink
Log in

Reduced Survival of Rectal Cancer Patients With Increased Tumor Epidermal Growth Factor Receptor Levels

  • Original Contribution
  • Published:
Diseases of the Colon & Rectum

Abstract

PURPOSE: The epidermal growth factor receptor and its various ligands (epidermal growth factor, transforming growth factor-alpha, amphiregulin, heparin-binding epidermal growth factor, heregulin, and betacellulin) have been implicated in growth and regeneration of intestinal mucosa and might be related to the development and progression of gastrointestinal tumors. Although some studies have investigated levels of epidermal growth factor receptor by radioligand binding studies, none of them have further analyzed these levels in patients with rectal cancer and investigated their prognostic value. METHODS: We quantitatively determined tumor epidermal growth factor receptor levels in 38 patients with colorectal cancer compared with adjacent normal mucosa by iodine-125–labeled epidermal growth factor binding studies and Scatchard analysis. Patients were followed up for 49.5 ± 32.2 (range, 2–120) months. RESULTS: Epidermal growth factor receptor capacity was increased in invasive colorectal carcinomas according to T classification (P < 0.001), tumors with lymph node infiltration (P = 0.038), and advanced International Union Against Cancer stage (P < 0.001). Survival of colorectal cancer was reduced in patients with advanced International Union Against Cancer stage (P < 0.001), tumors with positive lymph nodes (P < 0.001), and tumors with elevated epidermal growth factor receptor levels (P = 0.024). In rectal cancer patients, poor prognosis was associated with advanced International Union Against Cancer stage (P = 0.029), tumors with lymph node infiltration (P = 0.040), and increased epidermal growth factor receptor levels (P = 0.002). Multivariate Cox regression analysis indicated that elevated levels of epidermal growth factor receptor were an independent predictor of reduced survival in patients with rectal cancer (P = 0.005). CONCLUSION: The epidermal growth factor receptor/ligand system appears to be involved in tumor development and tumor progression of colorectal carcinomas, with prognostic implication especially in patients with invasive rectal carcinomas. These patients might take advantage of therapies that specifically block epidermal growth factor receptor–mediated signal transduction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. MB Sporn AB Roberts (1985) ArticleTitleAutocrine growth factors and cancer Nature 313 745–747

    Google Scholar 

  2. S Cohen G Carpenter L King (1980) ArticleTitleEpidermal growth factor-receptor-protein kinase interactions J Biol Chem 258 4834–4842

    Google Scholar 

  3. A Ullrich J Schlessinger (1990) ArticleTitleSignal transduction by receptors with tyrosine kinase activity Cell 61 203–212

    Google Scholar 

  4. E Tahara (1995) ArticleTitleGenetic alterations in human gastrointestinal cancers Cancer 75 1410–1417

    Google Scholar 

  5. J Downward P Parker MD Waterfield (1985) ArticleTitleAutophosphorylation sites in the epidermal growth factor receptor Nature 311 483–485

    Google Scholar 

  6. G Carpenter S Cohen (1979) ArticleTitleEpidermal growth factor Annu Rev Biochem 48 193–216

    Google Scholar 

  7. AB Schreiber TA Libermann I Lax Y Yarden J Schlinger (1983) ArticleTitleBiological role of epidermal growth factor-receptor clustering J Biol Chem 258 846–853

    Google Scholar 

  8. J Downward Y Yarden E Mayes et al. (1984) ArticleTitleClose similarity of epidermal growth factor receptor and v-erb-B oncogen protein sequences Nature 307 521–527

    Google Scholar 

  9. LT Malden U Novak AW Burgiss (1989) ArticleTitleExpression of transforming growth factor alpha messenger RNA in the normal and neoplastic gastro-intestinal tract Int J Cancer 43 380–384

    Google Scholar 

  10. S Tanaka K Imanishi M Yoshihara et al. (1991) ArticleTitleImmunoreactive transforming growth factor alpha is commonly present in colorectal neoplasia Am J Pathol 139 123–129

    Google Scholar 

  11. RJ Coffey GD Shipley HL Moses (1986) ArticleTitleProduction of transforming growth factors by human colon cancer lines Cancer Res 46 1164–1169

    Google Scholar 

  12. MA Anzano D Riemann, W Prichett DF Bowen-Pope R Greig (1989) ArticleTitleGrowth factor production by human colon carcinoma cells Cancer Res 49 2898–2904

    Google Scholar 

  13. W Yasui H Sumiyoshi J Hata et al. (1988) ArticleTitleExpression of epidermal growth factor in human gastric and colonic carcinomas Cancer Res 48 137–141

    Google Scholar 

  14. RJ Steele BE Kelly O Eremin (1990) ArticleTitleEpidermal growth factor receptor expression in colorectal cancer Br J Cancer 77 1352–1354

    Google Scholar 

  15. E Rothbauer K Mann B Wiebecke et al. (1989) ArticleTitleEpidermal growth factor receptors and epidermal growth factor-like activity in colorectal mucosa, adenomas and carcinomas Klin Wochenschr 67 518–513

    Google Scholar 

  16. PG Koenders WH Peters T Wobbes LV Beex FM Nagengast TJ Benrad (1992) ArticleTitleEpidermal growth factor receptor levels are lower in carcinomatous than normal colorectal tissue Br J Cancer 65 189–192

    Google Scholar 

  17. P Borlinghaus S Wieser R Lamerz (1993) ArticleTitleEpidermal growth factor, transforming growth factor-a, and epidermal growth factor receptor content in normal and carcinomatous gastric and colonic tissue Clin Invest 71 903–907

    Google Scholar 

  18. J Mendelsohn (2000) ArticleTitleBlockade of receptors for growth factors Clin Cancer Res 6 747–753

    Google Scholar 

  19. J Baselga (2000) ArticleTitleNew therapeutic agents targeting the epidermal growth factor receptor J Clin Oncol 18 54–59

    Google Scholar 

  20. F Ciardiello G Tortora (2001) ArticleTitleA novel approach in the treatment of cancer Clin Cancer Res 7 2958–2970

    Google Scholar 

  21. A Pfeiffer E Rothbauer B Wiebecke E Pratschke HJ Kraemling K Mann (1990) ArticleTitleIncreased epidermal growth factor receptors in gastric carcinomas Gastroenterology 98 961–967

    Google Scholar 

  22. PJ Munson D Rodbard (1980) ArticleTitleLIGAND Anal Biochem 107 159–171

    Google Scholar 

  23. DE Neal C Marsh MK Bennett et al. (1985) ArticleTitleEpidermal growth factor receptors in human bladder cancer Lancet 1 366–368

    Google Scholar 

  24. JR Sainsbury JR Farndon GV Sherbet AL Harris (1985) ArticleTitleEpidermal growth-factor receptors and oestrogen receptors in human breast cancer Lancet 1 364–366

    Google Scholar 

  25. Y Itakura H Sasano C Shiga et al. (1994) ArticleTitleEpidermal growth factor receptor overexpression in esophageal carcinoma Cancer 74 795–804

    Google Scholar 

  26. R Kopp M Ruge E Rothbauer et al. (2002) ArticleTitleImpact of epidermal growth factor (EGF) radioreceptor analysis on long term survival of gastric cancer patients Anticancer Res 22 1161–1168

    Google Scholar 

  27. K Koretz P Schlag P Möller (1990) ArticleTitleExpression of epidermal growth factor in normal colorectal mucosa, adenoma and carcinoma Virchows Arch A Pathol Anat 416 343–349

    Google Scholar 

  28. CA Maurer H Friess B Kretschman et al. (1998) ArticleTitleIncreased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2 Hum Pathol 29 771–777

    Google Scholar 

  29. S Higashiyama JA Abraham J Miller JC Fiddes M Klagsbrun (1991) ArticleTitleA heparin-binding growth factor secreted by macrophage-like cells that is related to EGF Science 252 936–939

    Google Scholar 

  30. A Ullrich L Coussens JS Hayflick et al. (1984) ArticleTitleHuman epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells Nature 309 418–425

    Google Scholar 

  31. NR Lemoine S Jain F Silvestre et al. (1991) ArticleTitleAmplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer Br J Cancer 64 79–83

    Google Scholar 

  32. H Masui A Wells CS Lazar MG Rosenfeld GN Gill (1991) ArticleTitleEnhanced tumorigenesis of NR6 cells which express non-down regulating epidermal growth factor receptors Cancer Res 51 6170–6175

    Google Scholar 

  33. JL Countaway IC Northwood RJ Davis (1989) ArticleTitleMechanism of phosphorylation of the epidermal growth factor receptor at threonine 669 J Biol Chem 264 10828–35

    Google Scholar 

  34. R Kopp B Noelke G Sauter FW Schildberg G Paumgartner A Pfeiffer (1991) ArticleTitleAltered protein kinase C activity in biopsies of human colonic adenomas and carcinomas Cancer Res 51 205–210

    Google Scholar 

  35. M Kusonoki Y Sakanoue T Hatada H Yanagi T Yamamura J Utsunomiya (1992) ArticleTitleProtein kinase C activity in human colonic adenoma and colorectal carcinoma Cancer 69 24–30

    Google Scholar 

  36. G Verstovsek A Byrd MR Frey et al. (1998) ArticleTitleColonocyte differentiation is associated with increased expression and altered distribution of protein kinase C isoenzymes Gastroenterology 115 75–85

    Google Scholar 

  37. R Emkey CR Kahn (1997) ArticleTitleCross-talk between phorbol ester-mediated signaling and tyrosine kinase proto-oncogenes. I. Activation of protein kinase C stimulates tyrosine phosphorylation and activation of ErbB2 and ErbB3 J Biol Chem 272 31172–81

    Google Scholar 

  38. N Chen WY Ma QB She et al. (2001) ArticleTitleTransactivation of the epidermal growth factor receptor is involved in 12-O-tetradecanoylphorbol-13-acetate-induced signal transduction J Biol Chem 14 46722–8

    Google Scholar 

  39. P Maruvada AE Levine (1999) ArticleTitleIncreased transforming growth factor-alpha levels in human colon carcinoma cell lines over-expressing protein kinase C Int J Cancer 80 72–77

    Google Scholar 

  40. E Odintsova T Sugiura F Berditchevski (2000) ArticleTitleAttenuation of EGF receptor signalling by a metastasis suppressor, the tetraspanin CD82/KAI-1 Curr Biol 10 1009–1012

    Google Scholar 

  41. R Goldman RB Levy E Peles Y Yarden (1990) ArticleTitleHeterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells Biochemistry 29 11024–8

    Google Scholar 

  42. N Gill A Malik A Potti R Talukdar A Saberi SA Mehdi (2002) ArticleTitleHER-2/neu overexpression in colonic malignancies Gastroenterology 122 248–249

    Google Scholar 

  43. S Venkateswarlu DM Dawson P St Clair A Gupta JK Willson MG Brattain (2002) ArticleTitleAutocrine heregulin generates growth factor independence and block apoptosis in colon cancer cells Oncogene 21 78–86

    Google Scholar 

  44. M Bos J Mendelsohn YM Kim et al. (1997) ArticleTitlePD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner Clin Cancer Res 3 2099–2106

    Google Scholar 

  45. J Mendelsohn (1997) ArticleTitleEpidermal growth factor receptor inhibition by a monoclonal antibody as anticancer therapy Clin Cancer Res 3 2703–2707

    Google Scholar 

  46. WE Karnes SG Weller PN Adjei et al. (1998) ArticleTitleInhibition of epidermal growth factor receptor kinase induces protease-dependent apoptosis in human colon cancer cells Gastroenterology 114 930–939

    Google Scholar 

  47. G Partik K Hochegger M Schörkhuber B Marian (1999) ArticleTitleInhibition of epidermal growth factor receptor dependent signalling by tyrphostins A25 and AG1478 blocks growth and induces apoptosis in colorectal tumor cells in vitro J Cancer Res Clin Oncol 125 379–388

    Google Scholar 

  48. PJ Jensen U Rodeck (1993) ArticleTitleAutocrine/paracrine regulation of keratinocyte urokinase plasminogen activator through the TGF-alpha/EGF receptor J Cell Physiol 155 333–339

    Google Scholar 

  49. E Lengyel S Ried MM Heiss C Jaeger M Schmitt H Allgayer (2001) ArticleTitleRas regulation of urokinase-type plasminogen activator Methods Enzymol 333 105–116

    Google Scholar 

  50. F Ciardiello R Caputo R Bianco et al. (2001) ArticleTitleInhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor Clin Cancer Res 7 1459–1465

    Google Scholar 

  51. G Gonzalez T Crombet M Catala et al. (1998) ArticleTitleA novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein Ann Oncol 9 431–435

    Google Scholar 

  52. G Lammering TH Hewit WT Hawkins et al. (2001) ArticleTitleEpidermal growth factor as a genetic therapy target for carcinoma cell radiosensitization J Natl Cancer Inst 93 921–929

    Google Scholar 

  53. SM Huang PM Harari (2000) ArticleTitleModulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas Clin Cancer Res 6 2166–2174

    Google Scholar 

  54. C Camma M Giunta F Fiorica L Pagliaro A Craxi M Cottone (2000) ArticleTitlePreoperative radiotherapy for resectable rectal cancer JAMA 284 1008–1015

    Google Scholar 

  55. E Kapiteijn CA Marijnen ID Nategaal et al. (2001) ArticleTitlePreoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer N Engl J Med 345 638–646

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Klinikum Grosshadern, University of Munich, Munich, Germany, and the Department of Endocrinology, Diabetes, and Nutrition, Klinikum Benjamin Franklin, Free University, Berlin, Germany

    Reinhard Kopp M.D., Elisabeth Rothbauer M.D., Elisabeth Mueller M.D., Friedrich Wilhelm Schildberg M.D., Karl-Walter Jauch M.D. & Andreas Pfeiffer M.D.

Authors
  1. Reinhard Kopp M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elisabeth Rothbauer M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elisabeth Mueller M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Friedrich Wilhelm Schildberg M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Karl-Walter Jauch M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Andreas Pfeiffer M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Kopp, R., Rothbauer, E., Mueller, E. et al. Reduced Survival of Rectal Cancer Patients With Increased Tumor Epidermal Growth Factor Receptor Levels. Dis Colon Rectum 46, 1391–1399 (2003). https://doi.org/10.1007/s10350-004-6756-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10350-004-6756-1

Keywords

Search

Navigation